martes, 2 de julio de 2013

Decision support boosts appropriate use of HPV vaccine | Agency for Healthcare Research & Quality (AHRQ)

Decision support boosts appropriate use of HPV vaccine | Agency for Healthcare Research & Quality (AHRQ)

AHRQ--Agency for Healthcare Research and Quality: Advancing Excellence in Health Care

Decision support boosts appropriate use of HPV vaccine

Health Information Technology

Providing families and clinicians with information to support decisions about starting and completing the human papillomavirus (HPV) vaccine series increases appropriate use of the vaccine. The HPV vaccine is effective in preventing some types of cervical cancer and requires a total of three shots given over 6 months. A study supported by AHRQ evaluated the impact of education and electronic alerts on vaccination rates. Electronic alerts for clinicians were most likely to impact delivery of the first shot, while education and reminders for families were tied to receipt of shots two and three.
For more details, see "The Implementation and Acceptability of an HPV Vaccination Decision Support System Directed at Both Clinicians and Families," which appeared in the 2012 American Medical Informatics Association Annual Symposium Proceedings. "Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt" appeared in the May 2013 issue of Pediatrics.
Current as of July 2013
Internet Citation: Decision support boosts appropriate use of HPV vaccine: Health Information Technology. July 2013. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/newsletters/research-activities/13jul/0713RA7.html

No hay comentarios: